uso 21412
A Phase I Study of FT576 as Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma (FT576-101)
Disease Types: Cellular & Gene
Available at:
Disease Types: Cellular & Gene
Available at: